DrugPatentWatch Database Preview
Patent: 8,236,356
» See Plans and Pricing
Summary for Patent: 8,236,356
Title: | Growth medium for Clostridium histolyticum |
Abstract: | The present invention provides improved media for the cultivation of Clostridium histolyticum and culture supernatants for the biotechnological production of collagenase enzymes. The nutrient media according to the invention comprise one or more peptones from a non-mammalian source, preferably plant-derived peptones. The media can additionally comprise fish gelatin. The invention provides media, culture supernatants comprising Clostridium histolyticum collagenase, and methods to produce said collagenase. |
Inventor(s): | Suppmann; Bernhard (Weilheim, DE), Hoelke; Werner (Penzberg, DE), Hoffmann; Artur (Wolfratshausen, DE), Marx; Thomas (Penzberg, DE), Sonn; Kirsten (Penzberg, DE), Thalhofer; Johann-Peter (Weilheim, DE) |
Assignee: | Roche Diagnostics Operations, Inc. (Indianapolis, IN) |
Application Number: | 12/478,306 |
Patent Claims: | see list of patent claims |
Details for Patent 8,236,356
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Smith And Nephew | SANTYL | collagenase | OINTMENT;TOPICAL | 101995 | 001 | 1965-06-04 | Start Trial | Roche Diagnostics Operations, Inc. (Indianapolis, IN) | 2028-06-11 | RX | search | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 8,236,356
Country | Patent Number | Estimated Expiration |
---|---|---|
United States of America | 2010086971 | Start Trial |
Singapore | 158025 | Start Trial |
Singapore | 179458 | Start Trial |
South Korea | 101157437 | Start Trial |
South Korea | 20090129362 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |